HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Another small supernumerary marker chromosome derived from chromosome 9 in a Klinefelter patient.

Abstract
Marker chromosomes are very rare in Klinefelter patients and phenotypic findings are related to the affected chromosomal region. The phenotypic effects of small supernumerary marker chromosomes (sSMC) range from multiple malformations/mental retardation to no effect (ie a normal phenotype). This wide spectrum of phenotypes is due to the origin, structure and gene content of the marker chromosome. The first Klinefelter case with sSMC 9 was published by Liehr et al in 2005. The present case was referred for chromosomal analysis because of dysmorphic features, speech delay and mild mental retardation. Conventional cytogenetic analysis revealed the 47XXY karyotype in 17 metaphases and the 48 XXY + marker karyotype in eight metaphases. Fluorescence in situ hybridization (FISH) analysis to identify the marker chromosome was performed using the LSI p16 (9p21) Spectrum Orange/CEP 9 SpectrumGreen Probe (Vysis CDKN2A/CEP 9 FISH Probe) and partial trisomy 9 mosaicism was confirmed in this patient. To our knowledge, this is the second case of Klinefelter syndrome with a small supernumerary marker chromosome derived from chromosome 9.
AuthorsT Gulten, O Gorukmez, O Gorukmez, M Karkucak, M Ture, T Yakut
JournalThe West Indian medical journal (West Indian Med J) Vol. 61 Issue 9 Pg. 924-7 (Dec 2012) ISSN: 0043-3144 [Print] Jamaica
PMID24020236 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Genetic Markers
Topics
  • Child, Preschool
  • Chromosome Disorders (diagnosis, genetics)
  • Chromosomes, Human, Pair 9 (genetics)
  • Genetic Markers (genetics)
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Klinefelter Syndrome (genetics)
  • Male
  • Mosaicism
  • Phenotype
  • Trisomy (genetics)
  • Uniparental Disomy (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: